Intended for Canadian Healthcare Professionals only

Frequently Asked Questions

Home / FAQs

For Canadian healthcare professionals only.

Please note: Local policy and the Product Monograph supersede this FAQ. Follow your hospital’s transfusion and emergency haemostasis guidelines.

Special clinical scenarios

If viscoelastic testing or Clauss supports low fibrinogen, give 50 to 70 mg per kg, then re-check. Integrate with MHP components.

Use protocolized dosing guided by Clauss or ROTEM. Coordinate with perfusion and transfusion medicine. 

Treat when fibrinogen is below target. Early replacement is associated with improved hemostasis. Coordinate with obstetrics and anesthesia.

Target-based dosing guided by Clauss or viscoelastic testing within surgical and transfusion protocols.

Consult pediatric hematology. Dosing is weight-based and guided by lab targets.

Manage per protocol. Fibryga restores substrate for clot formation but does not treat fibrinolysis. Use antifibrinolytics as indicated.